Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-08 09:33 • The Motley Fool Positive Axe Cap view: Selective

Supermicro is experiencing record AI infrastructure demand with growth in liquid cooling and rack-scale systems. However, the key investment focus has shifted from revenue growth to whether the company can achieve stronger profit margins, improved working-capital efficiency, and sustainable free cash flow at scale.

Axe note: Strong AI demand at Supermicro highlights a shift from growth to profitability, with clear implications for rand-sensitive tech plays.

2026-10-08 09:30 • The Motley Fool Positive Axe Cap view: Selective

Nutex Health and Elevance Health are recommended as undervalued healthcare stocks despite strong year-to-date performance. Nutex, a small-cap hospital operator, trades at less than 9x trailing earnings with exceptional EPS growth of 2,785% year-over-year. Elevance, a major health insurer, trades at a forward P/E of 14.52 below its five-year average, with consistent dividend increases and strong earnings guidance for 2026-2027.

Axe note: Nutex Health and Elevance Health offer compelling growth and value despite their strong recent performance.

2026-10-08 09:22 • The Motley Fool Positive Axe Cap view: Neutral

Dutch Bros has experienced a stock price pullback since July, reaching 52-week lows due to rising input costs and increased capital expenditures. However, the company continues robust expansion with 1,225 locations (up from 1,043 year-over-year) and maintains its target of 7,000 U.S. locations long-term. First-half 2026 revenue grew 33% to $939 million with 31% net income growth, while 2026 guidance implies 40% yearly revenue growth. With a declining valuation (P/E of 55, forward P/E of 39), the article suggests the recent price drop presents a buying opportunity for long-term investors.

Axe note: Strong US expansion contrasts with limited South African relevance, with rand exposure to watch.